机构名称：
¥ 9.0
ACA抗抑制剂抗体APC激活的蛋白C apla抗磷脂抗体APS抗磷脂抗体综合征在抗凝血酶中； antithrombin III AvWS acquired von Willebrand syndrome CLSI Clinical Laboratory Standards Institute (formerly NCCLS) DIC disseminated intravascular coagulation DOAC direct oral anticoagulant dRVVT dilute Russell viper venom time DTI direct thrombin inhibitor ELISA enzyme-linked immunosorbent assay FDP fibrin degradation products (aka fibrin split products) FEU fibrinogen equivalent units FVL factor V Leiden HIT heparin-induced thrombocytopenia HMWK high-molecular-weight kininogen HMWM high-molecular-weight multimer HSP Henoch-Schönlein purpura INR international normalized ratio ISI international sensitivity index ISTH International Society on Thrombosis and Haemostasis LMWH low molecular weight heparin NHLBI National Heart, Lung, and Blood Institute NIH National Institutes of Health NORD National Organization for Rare Disorders PAI-1 plasminogen activator inhibitor-1 PF4 platelet factor 4 PT prothrombin time PTT partial thromboplastin time RT reptilase time RVVT Russell viper venom time SLE systemic lupus erythematosus SSC Scientific和标准化小组委员会（ISTH的）TEG®血栓射击TFPI组织因子途径抑制剂TPA组织纤溶酶原激活物；组织型纤溶酶原激活剂TT凝血酶时间；凝血酶凝结时间； TCT TCT TTP血栓细胞减少紫菜UFH未分离的肝素VTE静脉血栓栓塞VWD VON WILLEBRAND疾病vwf vwf von von von von von von von willebrand因子
止血手册
主要关键词
相关文件推荐
